Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pegloticase for treating refractory chronic gout.
George RL Jr, Sundy JS. George RL Jr, et al. Among authors: sundy js. Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Drugs Today (Barc). 2012. PMID: 22844655 Review.
Quality of life and disability in patients with treatment-failure gout.
Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, Maroli A, Huang B; Gout Natural History Study Group, Sundy JS. Becker MA, et al. Among authors: sundy js. J Rheumatol. 2009 May;36(5):1041-8. doi: 10.3899/jrheum.071229. Epub 2009 Mar 30. J Rheumatol. 2009. PMID: 19332629
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland LW, Huang W, Waltrip RW 2nd, Maroli AN, Horowitz Z; Pegloticase Phase 2 Study Investigators. Sundy JS, et al. Arthritis Rheum. 2008 Sep;58(9):2882-91. doi: 10.1002/art.23810. Arthritis Rheum. 2008. PMID: 18759308 Clinical Trial.
Refractory gout: what is it and what to do about it?
Fels E, Sundy JS. Fels E, et al. Among authors: sundy js. Curr Opin Rheumatol. 2008 Mar;20(2):198-202. doi: 10.1097/BOR.0b013e3282f4eff5. Curr Opin Rheumatol. 2008. PMID: 18349751 Review.
78 results